U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. For Industry
  3. Medical products for rare diseases and conditions
  4. Personal Stories About Rare Diseases
  1. Medical products for rare diseases and conditions

Personal Stories About Rare Diseases

Patients with rare diseases offer a unique perspective about their condition and their experience is important to understand to help advance therapies for rare diseases. The stories below were captured to tell their stories and help the rare disease community understand more about the patient experience. These stories are critical to inform medical product development and regulation.

FDA experts also discuss their work on rare diseases and the widespread efforts across the FDA to promote safe, effective and innovative medical products for patients.

Population estimates may change over time and there are different definitions of rare diseases.  See Developing Products for Rare Diseases and Conditions for more information. The personal opinions and views expressed in these videos do not reflect FDA's official position. 


Stories from the Rare Disease Community

Braulio Hernandez - Hodgkin’s Lymphoma

Lauren Edwards - Gaucher Disease

Shawn and Harper - SCN2A-related disorder

See more stories from the rare disease community.


Rare Disease Work Across the FDA

Aaron Friedman - Regulatory Counsel for the Office of Orphan Products Development

Julienne Vaillancourt - Rare Disease Liaison for the Center for Biologics Evaluation and Research

Kerry Jo Lee- Acting Associate Director for Rare Diseases for Center for Drugs Evaluation & Research

See more stories about FDA's rare disease work. 


 

 



Back to Top